Stragen Pharma Sa

Chemgenex Pharmaceuticals, Inc.

Oncopharm Corporation

Julie Blanchard

Jean-Pierre Robin

Robert Dhal

Ludovic Chauviat

Jean-Pierre Marie

Nina Radosevic

Florence Fournier

Gilles Dujardin

Sylvie Rouaud

Sandra Charbonnel

Chrystelle Gilet

Sylvie Cavoleau

Sandrine Poutot

Laurent Girodier

Laurence Mevelec

Frederick Maloisel

François-Xavier Mahon

Hervé Maisonneuve

The present invention concerns a new general process for asymmetric hemisynthesis of harringtonines and their analogs, that are alkaloids used in chemotherapy. This process comprises direct esterification of a natural cephalotaxine with an acylating compound constituted of a side chain precursor which backbone and functionalization are entirely preformed. The invention also concerns a natural, synthetic or semi-synthetic harringtonines including their tautomeric forms and their salts of the following formula: wherein n=2 (i.e. harringtonine) or n=3 (i.e. homoharringtonine),in which the total content of impurities, possibly including enantiomeric forms, is lower than 1%, and/or the content of the major impurity is lower than 0.9%, and/or the chromatographic assay exhibits a harringtonines content higher than 97.5%.

Cephalotaxane derivatives and their processes of preparation and purification

The present invention concerns a method of treating chronic myelogenous leukemia, a related myeloproliferative disorder or a Ph-positive acute lymphocytic leukemia in a subject animal, comprising: In a preferred embodiment, the animal is a human being.

Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents

The present invention concerns a new general process for asymetric hemisynthesis of harringtonines and their analogs, that are alcaloids used in chimiotherapy. This process comprises direct esterification of a natural cephalotaxine with an acylating compound constituted of a side chain precursor which backbone and fonctionalization are entirely preformed.

Cephalotaxane derivatives and process for their preparation

Growing community of inventors

Rouillon, France

Julie Blanchard